Clinical Trials on Type 2 Diabetes Mellitus and Microalbuminuria
Total 18511 results
-
SanofiCompletedType 2 Diabetes MellitusEstonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain
-
Universidad de GuanajuatoCompleted
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Japan, India, Puerto Rico, Mexico
-
Merck Sharp & Dohme LLCCompleted
-
Hospital de Clinicas de Porto AlegreCompletedType 2 Diabetes MellitusBrazil
-
Population Health Research InstituteHamilton Health Sciences CorporationCompletedType 2 Diabetes MellitusCanada
-
University of PretoriaSouth African Sugar AssociationCompletedType 2 Diabetes MellitusSouth Africa
-
University of AlbertaCompleted
-
Novo Nordisk A/SCompletedDiabetes | Type 2 Diabetes MellitusTaiwan, Turkey, India, Algeria, Hong Kong, China, Ukraine
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Samsung Medical CenterNovartisCompletedType 2 Diabetes MellitusKorea, Republic of
-
Duke-NUS Graduate Medical SchoolSingHealth PolyclinicsCompletedType 2 Diabetes MellitusSingapore
-
AstraZeneca TurkeyOptimum Contract Research Organization, TurkeyCompletedType 2 Diabetes MellitusTurkey
-
Cheng Qing-fengUnknownType 2 Diabetes Mellitus
-
Merete Bechmann ChristensenNovo Nordisk A/SUnknownType 2 Diabetes MellitusDenmark
-
Sun Yat-sen UniversityUnknownType 2 Diabetes MellitusChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityUnknownType 2 Diabetes MellitusChina
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States, Netherlands, Canada
-
Lawson Health Research InstituteAstraZenecaCompleted
-
University of PalermoAstraZenecaCompleted
-
Dong-A ST Co., Ltd.CompletedType 2 Diabetes MellitusKorea, Republic of
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityUnknown
-
Merck Sharp & Dohme LLCTerminatedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Czech Republic, France, Korea, Republic of, Russian Federation, Spain, Mexico, Australia, Belgium, Denmark, Germany, Hungary, Netherlands, Puerto Rico, Greece, Taiwan
-
Valeritas, Inc.Integrated Medical DevelopmentCompletedType 2 Diabetes MellitusUnited States
-
SanofiCompletedType 2 Diabetes MellitusJapan
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Germany, Greece, Denmark, France
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusAustralia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Estonia, Romania, Finland, Netherlands, Argentina, Belgium, Germany, Portugal, United Kingdom, Greece, France, Puerto Rico
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusIreland, United Kingdom
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusFinland, Netherlands, Sweden
-
AstraZenecaEli Lilly and CompanyCompleted
-
Endocrine Research SocietyCompleted
-
Endocrine Research SocietyCompletedType 2 Diabetes MellitusCanada
-
University of ManitobaManitoba Institute of Child HealthCompleted
-
SanofiCompletedType 2 Diabetes MellitusUkraine
-
SanofiCompleted
-
Rocky Mountain Diabetes and Osteoporosis CenterCompletedType 2 Diabetes MellitusUnited States
-
Tehran University of Medical SciencesCompletedType 2 Diabetes MellitusIran, Islamic Republic of
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
Maastricht University Medical CenterCompleted
-
Karolinska InstitutetThe Swedish Research Council; Actelion; Swedish Heart Lung FoundationCompletedType 2 Diabetes MellitusSweden
-
Munich Municipal HospitalNovo Nordisk A/SUnknownType 2 Diabetes MellitusGermany
-
Wellstat TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Wellstat TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
CuraLifeRecruiting
-
Chong Kun Dang PharmaceuticalRecruitingEfficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 DiabetesType2 DiabetesKorea, Republic of